A recent study showed that DAPK1 regulates cancer stem cells in prostate cancer by interacting with the zinc finger E-box-binding homeobox-1 (ZEB1) to inhibit the Hippo/YAP signaling pathway in PCa-CD133(+) cells [54]. Here, DAPK1 is linked to cancer.